UnitedHealth Group Incorporated $UNH Shares Newly Purchased by Jacobsen Capital Management

Jacobsen Capital Management bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,508 shares of the healthcare conglomerate’s stock, valued at approximately $554,000.

Several other large investors also recently made changes to their positions in UNH. Nvwm LLC boosted its position in shares of UnitedHealth Group by 89.2% during the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 33 shares during the period. Wellington Altus USA Inc. grew its holdings in UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 33 shares in the last quarter. Security National Bank of SO Dak acquired a new stake in UnitedHealth Group in the 2nd quarter valued at approximately $29,000. Compass Wealth Management LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at $29,000. Finally, Aberdeen Wealth Management LLC acquired a new position in UnitedHealth Group during the 2nd quarter worth $31,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on UNH. Barclays decreased their price target on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating for the company in a research note on Wednesday, October 14th. Erste Group Bank cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, August 27th. Morgan Stanley increased their target price on shares of UnitedHealth Group from $529.00 to $531.00 and gave the company an “overweight” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $370.00 to $467.00 and gave the company a “hold” rating in a research note on Friday, July 17th. Finally, Evercore boosted their price target on shares of UnitedHealth Group from $400.00 to $480.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 7th. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $463.93.

UnitedHealth Group Stock Up 0.0%

NYSE:UNH opened at $410.72 on Wednesday. The business’s 50-day moving average price is $389.07 and its 200 day moving average price is $361.44. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The company had revenue of $112.70 billion for the quarter, compared to analysts’ expectations of $111.31 billion. During the same period in the prior year, the company earned $2.59 earnings per share. The company’s revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 20.62 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th.

Insiders Place Their Bets

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.